It has been reported that AREG, CD82, LIF, TBC1D14, TPSD1, DAPK1, FDX1, GLUL, and HS3ST1 affected the survival prognosis of HNSCC patients. Here, CD82 is linked to head and neck squamous cell carcinoma.